The rate of mothers who had an opioid-related diagnosis when delivering their baby increased 131% between 2010 and 2017, as the incidence of babies diagnosed with neonatal abstinence syndrome increased by 82% nationally during the same period. Given the focus on the implementation of medications to treat opioid use disorder (OUD) during the perinatal period, many medical, social services, and substance use disorder treatment providers have questions about how to best support both mother and child. This webinar will introduce the mother-child dyad in the context of OUD treatment and ways to promote healthy maternal child attachment.
Please join us on Tuesday, March 16th at 3pm EST as we welcome…
Hendrée E. Jones, PhD
• FORE Grantee; Executive Director at UNC Horizons; Professor, Department of OB/GYN at the University of North Carolina at Chapel Hill
Evette Horton, PhD
• Director of Child Clinical Services, Assistant Professor, Department of OB/GYN at University of North Carolina at Chapel Hill
Elisabeth Johnson, FNP, PhD
• Director of Medical Services, Clinical Assistant Professor, Department of OB/GYN at University of North Carolina at Chapel Hill
Essence Hairston, MSW, LCSWA, LCAS
• Program Manager at UNC Horizons Wake County; Clinical Instructor, Department of OB/GYN at University of North Carolina at Chapel Hill
With commentary from…
Mishka Terplan, MD, MPH, FACOG, DFASAM
• FORE Scientific Advisory Council Member; Senior Physician Research Scientist at Friends Research Institute
Leslie R. Walker-Harding, MD
• Chief Academic Officer and Senior Vice President at Seattle Children’s Hospital; Chair of the Department of Pediatrics at the University of Washington
Our presenters will also identify ways that trauma affects care and help articulate ways of supporting the mother-child dyad during physical separation, as well as navigating a successful reunification. An open Q&A session will follow the presentation.